Evidence map›Paper›PMID 30065304›Full record

ArticleNature communications2018

Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells.

Erika López-Arribillaga, Verónica Rodilla, Carlota Colomer, Anna Vert, Amy Shelton, Jason H Cheng, Bing Yan, Abel Gonzalez-Perez, Melissa R Junttila, Mar Iglesias and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Modes of Notch signalling in development and disease.Nature reviews. Molecular cell biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Significant Roles of NotchMolecules (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. When Viruses Cross Developmental Pathways.Frontiers in cell and developmental biology · 2021
    Review
  13. Article
  14. Cancer Stem Cells,Cells · 2020
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Erika López-ArribillagaCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.
Verónica RodillaCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0512-4179
Carlota ColomerCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.
Anna VertCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.
Amy SheltonDepartment of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Jason H ChengDepartment of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Bing YanCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.
Abel Gonzalez-PerezResearch Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Doctor Aiguader 88, 08003, Barcelona, Catalonia, Spain.
Melissa R JunttilaDepartment of Translational Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Mar IglesiasDepartment of Pathology, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.
Ferran TorresUniversitat Autonoma of Barcelona, Barcelona, 08193, Spain.
Joan AlbanellCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain.
Alberto VillanuevaLaboratori de Recerca Translacional, IDIBELL-Institut Català d'Oncologia Gran Via km 2.7, Hospitalet, 08907, Barcelona, Spain.
Anna BigasCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain. abigas@imim.es.
Christian W SiebelDepartment of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. siebel.christian@gene.com.
LLuís EspinosaCancer Research Program. CIBERONC. Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Doctor Aiguader 88, 08003, Barcelona, Spain. lespinosa@imim.es.
Hospital del Mar Research Institute · ESUniversitat Autònoma de Barcelona · ESGene Therapy Laboratory · FRHospital Del Mar · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversitat Pompeu Fabra · ES

Funding

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI16/00437
6 · The paper itself

Abstract

Delta ligands regulate Notch signaling in normal intestinal stem cells, while Jagged1 activates Notch in intestinal adenomas carrying active β-catenin. We used the Apc

Indexed as

AnimalsBiomarkers, TumorCarcinogenesisCell ProliferationEpithelial CellsGlucosyltransferasesHexosyltransferasesHumansIntestinal NeoplasmsIntracellular Signaling Peptides and ProteinsJagged-1 ProteinLigandsMembrane ProteinsMiceModels, BiologicalPrognosisBiomarkers, TumorGlucosyltransferasesHexosyltransferasesIntracellular Signaling Peptides and ProteinsJAG1 protein, humanJag1 protein, mouseJagged-1 ProteinLigandsMembrane ProteinsMFNG protein, humanMfng protein, mouseProteinsReceptor, Notch1

Identifiers

PMID30065304
PMCPMC6068201
OpenAlexW2884611389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.